Clarius Group LLC Has $426,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Clarius Group LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,326 shares of the company’s stock after selling 70 shares during the period. Clarius Group LLC’s holdings in HCA Healthcare were worth $426,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Norges Bank bought a new stake in HCA Healthcare during the 4th quarter worth $694,985,000. Royal Bank of Canada increased its holdings in HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the period. Capital World Investors grew its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the last quarter. Sanders Capital LLC lifted its stake in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after acquiring an additional 456,738 shares during the period. Finally, TD Asset Management Inc lifted its position in shares of HCA Healthcare by 230.5% in the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after purchasing an additional 385,854 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA traded down $1.41 during midday trading on Friday, reaching $359.26. The company had a trading volume of 106,621 shares, compared to its average volume of 1,155,022. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $369.41. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The business has a 50-day moving average price of $336.58 and a two-hundred day moving average price of $326.16. The stock has a market cap of $94.10 billion, a PE ratio of 17.98, a P/E/G ratio of 1.39 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.29 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Analyst Ratings Changes

A number of brokerages have commented on HCA. Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. TD Cowen cut their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Royal Bank of Canada boosted their price objective on HCA Healthcare from $329.00 to $378.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Four analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $344.06.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,707 shares of company stock valued at $3,793,606. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.